ANALYTICAL METHOD DEVELOPMENT & VALIDATION OF ETRAVIRINE IN ITS BULK DOSAGE FORM BY USING RP-HPLC METHOD AS PER ICH GUIDELINES

Authors

  • Somsubhra Ghosh Nalanda College of Pharmacy
  • Sailaja A
  • Ravikumar Bvv

Abstract

 

Objective: An accurate, precise, rapid and economical reverse phase high performance liquid chromatography (HPLC) method has been developed
and validated for the estimation of etravirine in pharmaceutical dosage forms, using an ultraviolet detector.
Method: Elution was carried out using a mobile phase consisting of HPLC grade acetonitrile and flow rate was set on 1 ml/minute at 271 nm wave
length. The retention time for etravirine was found to be 1.80 minutes.
Result: The method was found to be linear in the range of 10-60 μg/ml. In the linearity study, regression equation and correlation coefficient were
found to be y=16.95x+17.148 and 0.999, respectively. This method was rugged and robust in different testing criteria, limit of detection and limit
of quantification was found to be 0.514 μg/ml and 1.713 μg/ml respectively. Accuracy study was carried out in three different concentration level
i.e. 50, 100, 150% and % recovery of the method was found to be 98.6%, 99.08%, 99.17% respectively in three different levels and mean recovery
was 98.95% and hence method was accurate.
Conclusion: Results of all validation parameter were within the limits as per International Conference on Harmonization guideline.

Keywords: High performance liquid chromatography, Validation, Method development, Artemether, Accuracy, Precision.

References

Available from: http://www.drugs.com/etravirine.html. [Last accessed on 2014 May 08].

FDA Approval History - Drugs.com. Available from: http://www.etravirine/Intelenceetravirine.html. [Last accessed on 2014 May 08].

Rezk NL, White NR, Jennings SH, Kashuba AD. A novel LC-ESI-MS method for the simultaneous determination of etravirine, darunavir and ritonavir in human blood plasma. Talanta 2009;79:1372-8.

Abobo C, Wu L, John J, Joseph MK. LC-MS/MS determination of etravirine in rat plasma and its application in pharmacokinetic studies. J Natl Inst Health 2010;878(30):3181-6.

Babu GR, Rao AL, Rao JV. Development and validation of RP-HPLC method for quantitative analysis of etravirine in pure and pharmaceutical formulations. Int J Pharm 2013;3(4):747-52.

Abhilash PR, Rao JV. HPTLC method development and validation for determination of etravirine in bulk and tablet dosage form. Int J Pharm Biol Sci 2013;3(3):515-22.

Kumar PR, Chinnalalaiah R. Development and validation of a new RP-HPLC method for estimation of etravirine in bulk and pharmaceutical dosage form. Int J Pharma Sci 2013;3(4):291-4.

Thangabhalan B, Gollapudi C, Sunitha N, Babu MS. Stability indicating RP-HPLC method for the estimation of etravirine in pure and tablet dosage form. Int J Pharmamedix India 2013;1(4):581-91.

Published

2015-03-01

How to Cite

Ghosh, S., S. A, and R. Bvv. “ANALYTICAL METHOD DEVELOPMENT & VALIDATION OF ETRAVIRINE IN ITS BULK DOSAGE FORM BY USING RP-HPLC METHOD AS PER ICH GUIDELINES”. Asian Journal of Pharmaceutical and Clinical Research, vol. 8, no. 2, Mar. 2015, pp. 147-50, https://innovareacademics.in/journals/index.php/ajpcr/article/view/4063.

Issue

Section

Original Article(s)